The effectiveness of applying continuous care model on lapse and craving of patients that treated are with methadone maintenance therapy

The effectiveness of applying continuous care model on lapse and craving of patients that are treated with methadone maintenance therapy in Razi Educational and Treatment Center of Urmia 2016

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016042816564N6

Enrollment

Registered

2016-06-08

Start date

2016-05-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Opioid Dependency. Condition 2: Cannabis drug dependence. Condition 3: Sedative or hypnotic drug dependence. Condition 4: Cocaine dependence. Condition 5: Hallucinogenic drug dependence. Mental and behavioural disorders due to use of opioids Mental and behavioural disorders due to use of cannabinoids Mental and behavioural disorders due to use of sedatives or hypnotics Mental and behavioural disorders due to use of cocaine Mental and behavioural disorders due to use of hallucin

Interventions

Intervention 1: Continuous Care Model will be implemented on intervention group over a period of 3 months. This model consists of 4 stages which will be done individually. Orientation stage: This stag

Prevention

Continuous Care Model will be implemented on intervention group over a period of 3 months. This model consists of 4 stages which will be done individually. Orientation stage: This stage involves intro

Orientation stages will be implemented as well as for the control group but will differ in terms of time and expectations and future programs slightly. Because the purpose of the orientation stage to

Eligibility

Sex/Gender

All

Age

18 Years to 48 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being between 18-48 years old, the diagnostic criteria for opioid dependence, according to psychiatrist, passing at least 3 months of being treated with methadone maintenance therapy and residence in the city of Urmia Exclusion criteria: Psychological disorders that require hospitalization, use of antipsychotics and anticonvulsants at the time of entering the study and lack of willingness or ability to participate in the continuous care meetings

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Lapse. Timepoint: During the 3 months and 3 months before the study intervention. Method of measurement: Nominal-Lapse and absence check list.;Craving. Timepoint: before and during the 3 months of intervention. Method of measurement: Craving Questionnaire after leaving.	—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Namazpoor

Urmia University of Medical Science

razi_ psychitry@umsu.ac.ir+98 44 3346 4788

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026